Sign up for the QMED & MD+DI Daily newsletter.
CR Bard Settles Vaginal-Mesh Lawsuit
September 16, 2013
1 Min Read
CR Bard reportedly managed to avoid court time in one of its latest vaginal-mesh implant lawsuits. The case, originally set for trial in New Jersey, is said to have been nullified through a settlement. The settlement sum was not disclosed. This is the second case the company has managed to settle over alleged injuries associated with its Avaulta Plus insert.
In August, a federal jury in West Virginia ordered CR Bard to pay $2 million to a woman who was allegedly injured by the company's vaginal mesh device. This latest settlement is the second one since that trial.
In total, the company faces more than 8000 injury claims associated with its Avaulta product line. According to plaintiffs, the devices can make sexual intercourse painful and can lead to organ damage. CR Bard isn't the only company facing legal troubles with its vaginal mesh systems: Endo Health Solutions, Johnson & Johnson and Boston Scientific all face ongoing legal battles over alleged patient injuries. In most cases, plaintiffs allege that the implants shrunk over time, leading to complications.
The Avaulta implants by CR Bard were pulled from the market in 2012. At that time, the FDA required all vaginal mesh manufacturers to study sexual pain, infection and organ damage associated with the devices.
The settled trial was originally scheduled for September 23 in Atlantic City, NJ.
You May Also Like
Pedersen's POV graphic featuring the headshot of MD+DI Senior Editor Amanda Pedersen and a pull quote from the latest edition of her opinion column.
BioSig's Ridiculously Sparse Layoff Announcement Reeks of CallousnessFeb 26, 2024|3 Min Read
Your Smartwatch Can’t Measure Blood Glucose Levels… YetFeb 26, 2024|3 Min Read
Medtech in a Minute: Medtronic Pulls the Plug on Ventilators and MoreFeb 26, 2024|1 Min Read
The Good, The Bad, and The Ugly in Medtech DealsFeb 23, 2024|9 Slides